1 |
Evidence for overuse of cardiovascular healthcare services in high-income countries: protocol for a systematic review and meta-analysis
|
|
|
|
In: BMJ Open (2022)
|
|
BASE
|
|
Show details
|
|
2 |
Different Rates of Bioprosthetic Aortic Valve Failure With Perimount™ and Trifecta™ Bioprostheses
|
|
|
|
In: Front Cardiovasc Med (2022)
|
|
BASE
|
|
Show details
|
|
3 |
Switching of oral anticoagulants in atrial fibrillation: a cohort study using Australian general practice data
|
|
|
|
BASE
|
|
Show details
|
|
4 |
Potencialidades do estudo contextualizado do sistema cardiovascular para o desenvolvimento da linguagem científica
|
|
|
|
BASE
|
|
Show details
|
|
5 |
Molecular Epidemiology of G6PD Genotypes in Different Ethnic Groups Residing in Saharan and Sahelian Zones of Mauritania
|
|
|
|
In: ISSN: 2076-0817 ; Pathogens ; https://hal-amu.archives-ouvertes.fr/hal-03429269 ; Pathogens, MDPI, 2021, 10 (8), pp.931. ⟨10.3390/pathogens10080931⟩ (2021)
|
|
BASE
|
|
Show details
|
|
6 |
Associations between Cardiovascular Signal Entropy and Cognitive Performance over Eight Years
|
|
|
|
In: Entropy ; Volume 23 ; Issue 10 (2021)
|
|
BASE
|
|
Show details
|
|
8 |
Elastogenesis Correlates With Pigment Production in Murine Aortic Valve Leaflets
|
|
|
|
In: Front Cardiovasc Med (2021)
|
|
BASE
|
|
Show details
|
|
9 |
Oral, Tongue-Coating Microbiota, and Metabolic Disorders: A Novel Area of Interactive Research
|
|
|
|
In: Front Cardiovasc Med (2021)
|
|
BASE
|
|
Show details
|
|
10 |
Respiratory Sinus Arrhythmia in Children—Predictable or Random?
|
|
|
|
In: Front Cardiovasc Med (2021)
|
|
BASE
|
|
Show details
|
|
11 |
Utility of blood pressure measurements at an initial screening visit to identify Chinese children and adolescents with hypertension
|
|
|
|
BASE
|
|
Show details
|
|
12 |
Switching of oral anticoagulants in patients with nonvalvular atrial fibrillation: A narrative review
|
|
|
|
BASE
|
|
Show details
|
|
13 |
Psychophysiological Responses to Acute Cold Water Immersion
|
|
|
|
BASE
|
|
Show details
|
|
14 |
Implementation of cascade genetic screening for familial hypercholesterolemia: Design of the Swiss catch randomized controlled trial
|
|
|
|
In: EAS 2021 abstracts : European Atherosclerosis Society, vol. 331, pp. e184 (2021)
|
|
BASE
|
|
Show details
|
|
15 |
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
|
|
|
|
BASE
|
|
Show details
|
|
16 |
Minimizing the duration of laser Doppler flowmetry recordings while maintaining wavelet analysis quality: A methodological study
|
|
|
|
In: ISSN: 0026-2862 ; EISSN: 1095-9319 ; Microvascular Research ; https://hal-univ-avignon.archives-ouvertes.fr/hal-03291993 ; Microvascular Research, Elsevier, 2020, 131, ⟨10.1016/j.mvr.2020.104034⟩ (2020)
|
|
BASE
|
|
Show details
|
|
17 |
Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
|
|
|
|
In: Research outputs 2014 to 2021 (2020)
|
|
BASE
|
|
Show details
|
|
18 |
Factors that influence adherence to treatment plans amongst people living with cardiovascular disease: A review of published qualitative research studies
|
|
|
|
In: Research outputs 2014 to 2021 (2020)
|
|
BASE
|
|
Show details
|
|
19 |
Quality of life measured by EQ-5D at different treatment time points for coronary artery disease: protocol for a systematic review and meta-analysis
|
|
|
|
Abstract:
Introduction Cardiovascular disease is estimated to affect 423 million people globally. It caused 18 million deaths in 2017 and is projected to cost US$1 trillion by 2030 worldwide. Coronary artery disease (CAD) is the most common type of cardiovascular disease; CAD treatments can affect patients’ quality of life. Valuations of quality of life or health utilities are important for economic evaluations to ascertain relative health benefit when comparing treatments, and can be expected to change for individuals over time. The purpose of this systematic review is to estimate the quality of life of patients with CAD reported through the EuroQol 5 Dimension (EQ-5D) questionnaire, from short to longer term time points following different treatments. Methods and analysis PubMed, Embase, Web of Science, the Cochrane Database of Systematic Reviews and the EuroQol website will be systematically searched from January 2003–March 2020. Published, peer-reviewed, English language studies assessing quality of life of patients with CAD using the EQ-5D will be included. One researcher will conduct the search; two researchers will independently screen titles and abstracts for potential inclusion. Full texts of potentially eligible studies will be retrieved for a second round of independent screening against inclusion and exclusion criteria by two researchers. The final list of included studies will be assessed for risk of bias using the RoB 2 and Risk Of Bias In Non-randomized Studies - of Interventions (ROBINS-I) tools for randomised and non-randomised studies, respectively. Data extraction will be done by one researcher, with data extraction for a random 10% of included studies checked by a second researcher. Mean utility weights for individual studies will be combined using random effects model meta-analyses. A model will be run separately for each time point and treatment. Treatment time points of interest include baseline, 30 days, 6 months, 12–24 months and more than 24 months. Subgroup analysis of patients with diabetes who received interventional treatments—coronary artery bypass graft or percutaneous coronary intervention with or without stents, will be conducted for the same selected time points. Ethics and dissemination Ethics approval is not required for systematic reviews. Results of the review will be disseminated via publication in a peer-reviewed journal.
|
|
Keyword:
Cardiovascular medicine
|
|
URL: http://bmjopen.bmj.com/cgi/content/short/10/7/e039311 https://doi.org/10.1136/bmjopen-2020-039311
|
|
BASE
|
|
Hide details
|
|
20 |
Quality of life measured by EQ-5D at different treatment time points for coronary artery disease: protocol for a systematic review and meta-analysis
|
|
|
|
In: BMJ Open (2020)
|
|
BASE
|
|
Show details
|
|
|
|